These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Pathogenic effects of antigen-antibody reactions from a morphological viewpoint]. Lunzenauer K; Schneider W Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:88-91. PubMed ID: 4248368 [No Abstract] [Full Text] [Related]
44. Delayed hypersensitivity to insulin and its component polypeptide chains. Clark C; Munoz J J Immunol; 1970 Sep; 105(3):574-83. PubMed ID: 4195496 [No Abstract] [Full Text] [Related]
49. Approach to the patient with drug allergy. Schnyder B Med Clin North Am; 2010 Jul; 94(4):665-79, xv. PubMed ID: 20609856 [TBL] [Abstract][Full Text] [Related]
50. [Immunosuppressive therapy of myasthenia gravis]. Lechner H; Ott E; Aranibar A Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158 [No Abstract] [Full Text] [Related]
51. [Prolonged immunosuppressive therapy in children. Indications and contraindications]. Hager-Malecka B; Kobierska-Szcepańska A; Krysowska A; Karczewska K Pediatr Pol; 1973 Feb; 48(2):163-70. PubMed ID: 4804854 [No Abstract] [Full Text] [Related]
52. Steroid avoidance or withdrawal after kidney transplantation: a balancing act. Sprangers B; Vanrenterghem Y Transplantation; 2010 Aug; 90(4):350-2. PubMed ID: 20548264 [No Abstract] [Full Text] [Related]
53. Which patients with antiphospholipid antibody should be treated and how? Lockshin MD Rheum Dis Clin North Am; 1993 Feb; 19(1):235-47. PubMed ID: 8356257 [TBL] [Abstract][Full Text] [Related]
54. [Immunomodulated treatment of neurologic diseases]. Nordal HJ; Aarli JA; Nyland H; Vartdal F Tidsskr Nor Laegeforen; 1983 Oct; 103(30):2033-8. PubMed ID: 6658725 [No Abstract] [Full Text] [Related]
55. [Immediate and delayed allergic reactions in experimental sensitization with Ambrosia pollen]. Samoĭlov AV; Terekhova-Uvarova NA Vestn Akad Med Nauk SSSR; 1974; (11):16-9. PubMed ID: 4450718 [No Abstract] [Full Text] [Related]
56. Some factors influencing the serum IgE levels in atopic diseases. Johansson SG; Bennich H; Berg T; Högman C Clin Exp Immunol; 1970 Jan; 6(1):43-7. PubMed ID: 4190341 [TBL] [Abstract][Full Text] [Related]
57. [Immunosuppressive drug therapy]. Elonen E Duodecim; 1986; 102(22):1684-9. PubMed ID: 3803258 [No Abstract] [Full Text] [Related]
58. [Immunosuppressive treatment and its side effects]. Scheiffarth F Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064 [No Abstract] [Full Text] [Related]
59. Immediate and delayed hypersensitivity to corticosteroids. Basedow S; Eigelshoven S; Homey B J Dtsch Dermatol Ges; 2011 Nov; 9(11):885-8. PubMed ID: 21718445 [TBL] [Abstract][Full Text] [Related]